Elliott Charles Sigal

Affiliations

  • Director at Vir Biotechnology Inc. (VIR), 2024-06-03
  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2024-05-20
  • Director at Surface Oncology Inc. (SURF), 2023-09-08
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2023-07-03
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VIR $22.73 2,500 Director 10,000 2023-03-01 Filing
VIR $24.96 2,500 Director 7,500 2023-01-05 Filing
VIR $25.25 2,500 Director 5,000 2023-01-04 Filing
VIR $25.60 2,500 Director 2,500 2023-01-03 Filing
ADAP $1.56 15,000 Director 314,100 2016-05-19 Filing